Osteoporosis clinical trials

Explore recruiting osteoporosis clinical trials.

Recruiting osteoporosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Osteoporosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, parallel-group, active-controlled comparative study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of LY06006 compared with EU-Prolia in postmenopausal women with osteoporosis

Czechia, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

The Optimised use of Romosozumab Study

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Strategies for zoledronic acid post-denosumab discontinuation in postmenopausal osteoporosis

France

Therapeutic use (Phase IV) EU CTIS Study details

Treatment with zoledronate subsequent to denosumab in osteoporosis 2

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

A Randomized, Single-dose, Crossover, Two-period, Pilot Comparative Bioavailability Study of Alendronate 70 mg effervescent vs. Fosamax 70 mg tablets in Healthy Male and Female Subjects.

Czechia

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A randomised, open label, single dose, two periods, crossover study of the comparative pharmacokinetics of two alendronic acid formulations in healthy volunteers under fasted conditions: a pilot study.

Czechia

Human Pharmacology (Phase I)- Other EU CTIS Study details

Osteoporosis trials by city

Osteoporosis in Toronto Osteoporosis in Vancouver Osteoporosis in Montreal Osteoporosis in Calgary Osteoporosis in Edmonton Osteoporosis in Ottawa Osteoporosis in Winnipeg Osteoporosis in Quebec City Osteoporosis in Hamilton Osteoporosis in Kitchener Osteoporosis in London Osteoporosis in Halifax Osteoporosis in New York Osteoporosis in Los Angeles Osteoporosis in Chicago Osteoporosis in Houston

Other conditions

Ulcerative colitis Irritable bowel syndrome Celiac disease GERD Eosinophilic esophagitis Gastroparesis Rheumatoid arthritis Lupus Psoriatic arthritis Ankylosing spondylitis Osteoarthritis Knee osteoarthritis Sjogren's syndrome Scleroderma Fibromyalgia Psoriasis Eczema (atopic dermatitis) Acne Vitiligo Hidradenitis suppurativa Rosacea Alopecia areata Endometriosis Uterine fibroids